Potassium iodide is indicated as a thyroid-blocking agent to prevent the uptake of radioactive iodine, for example after a nuclear accident or during a nuclear medicine investigation before administering a radioiodinated compound, which is metabolised to iodide or which contains radioiodine impurities.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
Potassium iodide is the active ingredient of these drugs:
Hong Kong
Germany
Austria Germany
Germany
Lithuania
United Kingdom
Cyprus Spain
Spain
Potassium iodide is also found within below combination drugs:
ADDAMEL , ADDAVEN , ADDITRACE , EXPEC , GEMSTAIN , JODTHYROX , JUNIMIN , JUNYELT , NATIFAR , NUTRITRACE , NUTRYELT , SUPPLIVEN , TENTIL , THYRONAJOD , TRACUTIL , YODOCEFOL , YODUK COMPLEX , YOFOLVIT
Medicine agencies around the world have authorized marketing of this active ingredient according to these medication package inserts (MPIs):